Daily Bulletin

Men's Weekly

.

Alterity Therapeutics Announces Publication Demonstrating that ATH434 is Neuroprotective in Animal Model of Parkinsonian Disorder in the Journal of Parkinson's Disease

  • Written by PR Newswire Asia - Daily Bulletin Au RSS

Study demonstrates reduction of α-synuclein aggregation and preservation of neurons

Alterity Therapeutics Announces Publication Demonstrating that ATH434 is Neuroprotective in Animal Model of Parkinsonian Disorder in the Journal of Parkinson's Disease

MELBOURNE, Australia, Jan. 28, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today...

Read more: Alterity Therapeutics Announces Publication Demonstrating that ATH434 is Neuroprotective in Animal...

Business News

Integrating Marketing Automation Workflows with Headless CMS: Creating a Unified Engine for Scalable Growth

Marketing automation is a necessary component of modern engagement with customers. Automated emails, triggered campaigns, lead nurturing and lifecycle messaging enable brands to scale their messagin...

Daily Bulletin - avatar Daily Bulletin

Why Split Corrugated Conduits Are Essential For Protecting Electrical And Solar Installations

Modern electrical systems require reliable protection for wiring and cables to ensure safety, durability, and long-term performance. In residential, commercial, and industrial environments, conduits a...

Daily Bulletin - avatar Daily Bulletin

Launching Global Product Campaigns with Decoupled Content Architecture

There's perhaps no more challenging project for an international enterprise to pursue than a global product launch campaign. At the same time, various regions, languages, compliance standards, digit...

Daily Bulletin - avatar Daily Bulletin

Speed Dating For Business